GlassScriptPhysician profile
Daniel Fayard
NPI 1629414834
$7,722.92
in general payments reported to CMS, 2019-2025
38 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what a typical Epilepsy provider received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $85.48 · 2021: $1,100 · 2022: $1,415 · 2023: $1,889 · 2024: $1,494 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,134 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,134.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $1,668.82 | 2020-2025 | Xcopri |
| Livanova USA, INC. | $1,075.02 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $1,054.91 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Neurelis, INC. | $601.90 | 2021-2025 | Valtoco |
| Neuropace, INC. | $585.17 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $544.13 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $322.97 | 2019-2022 | |
| Medtronic, INC. | $314.98 | 2022-2024 | Sensight, Percept PC Brainsense |
| Amgen INC. | $138.23 | 2019-2023 | Aimovig |
| Lilly USA, LLC | $132.35 | 2019-2022 | |
| Argenx US, INC. | $130.94 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Catalyst Pharmaceuticals, INC. | $120.19 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $118.96 | 2021 | |
| Monteris Medical Corporation | $102.63 | 2021 | |
| Biocodex, INC. | $85.45 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fayard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.